NYRSY yields 1000000.00% · PFE yields 6.13%● Live data
📍 NYRSY pulled ahead of the other in Year 1
Combined, NYRSY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NYRSY + PFE for your $10,000?
Nyrstar NV engages in mining, smelting, and producing zinc, lead, and other base and precious metals primarily in Europe, Australia, Canada, and the United States. The company operates in Metals Processing and Mining segments. It offers zinc in concentrate from its mining operations; and refined market zinc products, including special high grade zinc, zinc galvanizing alloys, and zinc die-casting alloys for various applications and uses, such as construction and infrastructure, transport, industrial machinery, communications, electronics, and consumer products. The company also produces copper in concentrates and copper cathodes used in building construction, electrical and electronic products, transportation equipment, consumer products, and industrial machinery and equipment; and lead in concentrate primarily for the production of batteries. In addition, it offers gold and silver in concentrate and dore; indium and cadmium; and sulphuric acid for the production of fertilizers, fibers, paints, rubber, plastics, steel, detergents, and medicines. Nyrstar NV was founded in 2007 and is based in Zurich, Switzerland.
Full NYRSY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.